Likelihood of obstructive sleep apnea in people living with HIV in Cameroon – preliminary findings

Table 5 “Risk” of OSA with respect to HIV disease characteristics

	OSA				2 sided sig. of difference	Entire HIV+ sample
	No “risk” of OSA		“Risk” of OSA		2 sided sig. of difference	Entire HIV+ sample
	N	%	N	%		N	%
HIV genotype
HIV₁	8	42.1	5	31.3	0.679	13	37.1
HIV₂	1	5.3	2	12.5		3	8.6
HIV₁₊₂	0	0.0	1	6.3		1	2.9
Undetermined genotype	10	52.6	8	50.0		18	51.4
Age at diagnosis (years)
Mean ± SD	34.55 ± 9.84		37.24 ± 10.51		0.416	34.27 ± 9.29
20–24	6	28.6	3	17.6	0.425	9	23.7
≥25	15	71.4	14	82.4	0.425	29	76.3
Duration since diagnosis
<= 6 months	8	38.1	6	35.3	0.717	14	36.8
>6 months	13	61.9	11	64.7	0.717	24	63.2
CD4 count (count/mm³)
Mean ± SD	387.10 ± 150.58		490.33 ± 107.96		0.299	410.92 ± 144.90
<350	3	30.0	0	0.0	0.528	3	23.1
≥350	7	70.0	3	100.0	0.528	10	76.9
WHO disease stage
Stage 1	15	71.4	11	64.7	0.930	26	68.4
Stage 2	2	9.5	1	5.9		3	7.9
Stages 3–4	4	19.1	5	29.4		9	23.7
Routine check-ups in last 3 months
None	10	50.0	10	58.8	0.591	20	54.1
At least 1	10	50.0	7	41.2	0.591	17	45.9
Patient on HAART
Yes	8	38.1	6	35.3	1.00	14	36.8
No	13	61.9	11	64.7	1.00	24	63.2
HAART duration
Mean ± SD	61.11 ± 51.59		32.75 ± 32.27		0.201	47.76 ± 44.71
<6 months	2	22.2	2	25.0	1.00	4	23.5
≥6 months	7	77.8	6	75.0	1.00	13	76.5
HAART protocols		0.0				0
1st line	8	100.0	5	83.3	0.429	13	92.9
2nd line	0	0.0	1	16.7	0.429	1	7.1
Compliance last 30 days
Compliant	4	40.0	6	100.0	0.034 ^a	10	62.5
Not complaint	6	60.0	0	0.0	0.034 ^a	6	37.5
Complications in last 3 months
None	0	0.0	2	11.8	0.204	2	5.4
At least one	20	100.0	15	88.2	0.204	35	94.
Presence of other concurrent diseases
At least one	2	10.0	3	17.6	0.644	5	13.5
None	18	90.0	14	82.4	0.644	32	86.5

ISSN: 2398-2683